237 related articles for article (PubMed ID: 22654848)
1. Mouse models of follicular and papillary thyroid cancer progression.
Russo MA; Antico Arciuch VG; Di Cristofano A
Front Endocrinol (Lausanne); 2011; 2():119. PubMed ID: 22654848
[TBL] [Abstract][Full Text] [Related]
2. Modeling anaplastic thyroid carcinoma in the mouse.
Champa D; Di Cristofano A
Horm Cancer; 2015 Feb; 6(1):37-44. PubMed ID: 25420535
[TBL] [Abstract][Full Text] [Related]
3. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
Xu B; Ibrahimpasic T; Wang L; Sabra MM; Migliacci JC; Tuttle RM; Ganly I; Ghossein R
Thyroid; 2016 Nov; 26(11):1588-1597. PubMed ID: 27480016
[TBL] [Abstract][Full Text] [Related]
5. Where to set the threshold between well differentiated and poorly differentiated follicular carcinomas of the thyroid.
Albores-Saavedra J; Carrick K
Endocr Pathol; 2004; 15(4):297-305. PubMed ID: 15681853
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid.
Ito Y; Miyauchi A
Endocr J; 2009; 56(2):177-92. PubMed ID: 18703852
[TBL] [Abstract][Full Text] [Related]
7. The association of well-differentiated thyroid carcinoma with insular or anaplastic thyroid carcinoma; evidence for dedifferentiation in tumor progression.
Van der Laan BFAM; Freeman JL; Tsanq RW; Asa SL
Endocr Pathol; 1993 Dec; 4(4):215-221. PubMed ID: 32370456
[TBL] [Abstract][Full Text] [Related]
8. The Current Histologic Classification of Thyroid Cancer.
Asa SL
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):1-22. PubMed ID: 30717895
[TBL] [Abstract][Full Text] [Related]
9. Molecular and genetic markers of follicular-cell thyroid cancer: etiology and diagnostic and therapeutic opportunities.
Goyal N; Setabutr D; Abdulghani J; Goldenberg D
Adv Exp Med Biol; 2013; 779():309-26. PubMed ID: 23288646
[TBL] [Abstract][Full Text] [Related]
10. Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.
Nikitski AV; Rominski SL; Condello V; Kaya C; Wankhede M; Panebianco F; Yang H; Altschuler DL; Nikiforov YE
Thyroid; 2019 Oct; 29(10):1425-1437. PubMed ID: 31298630
[No Abstract] [Full Text] [Related]
11. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.
Nikiforova MN; Kimura ET; Gandhi M; Biddinger PW; Knauf JA; Basolo F; Zhu Z; Giannini R; Salvatore G; Fusco A; Santoro M; Fagin JA; Nikiforov YE
J Clin Endocrinol Metab; 2003 Nov; 88(11):5399-404. PubMed ID: 14602780
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
[TBL] [Abstract][Full Text] [Related]
13. Evolution of the histologic classification of thyroid neoplasms and its impact on clinical management.
Xu B; Ghossein R
Eur J Surg Oncol; 2018 Mar; 44(3):338-347. PubMed ID: 28554832
[TBL] [Abstract][Full Text] [Related]
14. Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial-type cytokeratins.
Fonseca E; Nesland JM; Höie J; Sobrinho-Simões M
Virchows Arch; 1997 Mar; 430(3):239-45. PubMed ID: 9099982
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation.
Amacher AM; Goyal B; Lewis JS; El-Mofty SK; Chernock RD
Am J Surg Pathol; 2015 Feb; 39(2):260-5. PubMed ID: 25321328
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas.
Pita JM; Banito A; Cavaco BM; Leite V
Br J Cancer; 2009 Nov; 101(10):1782-91. PubMed ID: 19809427
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance.
Acquaviva G; Visani M; Repaci A; Rhoden KJ; de Biase D; Pession A; Giovanni T
Histopathology; 2018 Jan; 72(1):6-31. PubMed ID: 29239040
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic Central Neck Dissection in Well-differentiated Thyroid Cancer.
Gršić K; Bumber B; Curić Radivojević R; Leović D
Acta Clin Croat; 2020 Jun; 59(Suppl 1):87-95. PubMed ID: 34219889
[TBL] [Abstract][Full Text] [Related]
19. New Insights in Thyroid Cancer and p53 Family Proteins.
Manzella L; Stella S; Pennisi MS; Tirrò E; Massimino M; Romano C; Puma A; Tavarelli M; Vigneri P
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635633
[TBL] [Abstract][Full Text] [Related]
20. Childhood thyroid cancer in England and Wales.
Harach HR; Williams ED
Br J Cancer; 1995 Sep; 72(3):777-83. PubMed ID: 7669594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
